acute%20coronary%20syndromes%20w_o%20persistent%20st-segment%20elevation
ACUTE CORONARY SYNDROMES W/O PERSISTENT ST-SEGMENT ELEVATION
Acute coronary syndromes refer to any constellation of clinical symptoms compatible with acute myocardial ischemia which may be life-threatening.
It encompasses unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).
Unstable angina is the ischemic discomfort that presents without persistent ST-segment elevation on ECG and without the presence of cardiac markers in the blood.
Non-ST-segment elevation myocardial infarction is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs.
The patient typically presents with ischemic-type chest pain that is severe and prolonged and may occur at rest or may be caused by less exertion than previous episodes.

Patient Education

Patient and Caregiver Education

  • Patient counseling tends to improve patient compliance and outcomes
  • Assess the functional capacity and the ability to carry out daily activities or work of the patient
  • Educate the patient and caregivers about unstable angina and cerebrovascular disease
    • Discuss the nature of the disease, drug regimens, lifestyle modifications and symptoms of angina
  • Before hospital discharge, provide instructions with respect to medication type, purpose, dose, frequency and side effects
  • Patient and caregivers should be instructed on what steps to take if anginal symptoms occur
    • Patient should be instructed to take sublingual nitrate and to seek emergency medical attention if 3 doses of nitrate fail to relieve pain
    • Explain to patient that if anginal symptoms change (eg pain more frequent, or occurs at rest, etc), they should contact their physician
  • Education should be a part of every patient encounter and should be tailored to the patient’s level of understanding
    • May be best to develop a plan with the patient and hold discussions over time so that patient is not overwhelmed by changing several behaviors all at one time (eg smoking, diet, exercise, etc)
  • Enlisting family members into the educational process to assist in achieving risk-factor modifications may be helpful
    • Eg cooking low-fat meals for the entire family or family exercise to further support the patient in changing risk behavior
    • Particularly important when screening of family members reveals common risk factors (eg hyperlipidemia, hypertension and obesity)
  • Inform schedule for follow-up after discharge
    • Low-risk medically treated patients and revascularized patients should return in 2-6 weeks
    • Higher risk patients should return within 2 weeks
    Annual influenza vaccination is recommended
  • Patient’s need for treatment of chronic musculoskeletal pain or discomfort should be assessed; pain relief should begin with Paracetamol, small doses of narcotics or nonacetylated salicylates
  • Antioxidant vitamins (eg vitamin E, C or beta-carotene) and folic acid with or without vitamins B6 and B12, should not be used for secondary prevention in UA/NSTEMI patients

Lifestyle Modification

Activity

  • Daily walking may be encouraged immediately after discharge
  • Exercise training can be started within 1-2 weeks after PCI or CABG to relieve ischemia
  • Discuss safety and timing of resumption of sexual activity
    • Usually 1-2 weeks for low-risk patients and 4 weeks for post-CABG
  • Give advice on resumption of driving (usually 1 week) if stressful driving conditions are avoided
  • Recommend timing of returning to work
  • Air travel may resume within 2 weeks of discharge, if patient travels with companion, carries sublingual GTN and takes airport transport to avoid rushing

Smoking Cessation

  • There are observational studies that show cigarette smoking increases the risk for CV disease events, insulin resistance and DM
    • Dose-dependent relationship exists between cigarettes smoked and CV risks
  • Primary goal is complete smoking cessation
  • Assess patient’s tobacco use and trongly urge patient and family to stop smoking
  • Identify which patients are willing to quit
    • Quit plan should be developed and pharmacological therapy (eg nicotine replacement, Bupropion, Varenicline), counseling and formal cessation programs should be provided, if needed
  • Aside from smoking cessation, avoidance of exposure to environmental smoke is also recommended
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Yesterday
The appropriate cutoff value in predicting combined cardiovascular outcomes in patients with type 2 diabetes (T2D) is 125 mm Hg for home morning systolic blood pressure (MSBP), suggests a new study.
01 Mar 2015
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.
06 Apr 2018

Female patients with coronary artery disease (CAD) have greater regression of coronary atherosclerosis than male patients despite a lower plaque burden at baseline, data from the GLAGOV trial have shown.

26 Apr 2018
Transcatheter aortic valve replacement (TAVR) in severe symptomatic aortic stenosis (AS) patients is superior to conventional surgical aortic valve replacement (SAVR) in terms of reducing life-threatening bleeding, new-onset atrial fibrillation and acute kidney injury, a recent meta-analysis has found.